Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
![Imatge de Publicacions](/sites/default/files/styles/3_1_small/public/2022-11/Portada_publicacions-petita_0.jpg?h=c6980913&itok=oZMso2V6)
Immunological and virological study of enfuvirtide-treated HIV-positive patients.
Genetic screen for monitoring severe acute respiratory syndrome coronavirus 3C-like protease.
Anti-human immunodeficiency virus type 1 (HIV-1) activity of lectins from Narcissus species.
HIV-1 resistance to the gp41-dependent fusion inhibitor C-34.
Fitness variations and their impact on the evolution of antiretroviral drug resistance.
Evidence for increased expression of regulatory cytokine receptors interleukin-12R and interleukin-18R in common variable immunodeficiency.
Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene Study.
Retroviruses and Opportunistic Infections--Tenth Conference. 10-14 February 2003, Boston, MA, USA.
Virus entry as a target for anti-HIV intervention.
New antiretroviral drugs and approaches to HIV treatment.